CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation
Ji, Lili1,2; Zheng, Zhiyong2; Shi, Liang2; Huang, Yinjie2; Lu, Bin2; Wang, Zhengtao1,2
刊名Biochimica et biophysica acta
2015-04
卷号1850期号:4页码:750-8
ISSN号0006-3002
DOI10.1016/j.bbagen.2015.01.005
文献子类Article
英文摘要Andrographolide (Andro) is reported to inhibit hepatoma tumor growth in our previous studies. This study aims to further search the critical signals involved in such Andro-induced inhibition.
语种英语
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/266489]  
专题中国科学院上海药物研究所
通讯作者Ji, Lili; Wang, Zhengtao
作者单位1.The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
2.Shanghai Key Laboratory of Complex Prescription and The MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;
推荐引用方式
GB/T 7714
Ji, Lili,Zheng, Zhiyong,Shi, Liang,et al. Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation[J]. Biochimica et biophysica acta,2015,1850(4):750-8.
APA Ji, Lili,Zheng, Zhiyong,Shi, Liang,Huang, Yinjie,Lu, Bin,&Wang, Zhengtao.(2015).Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation.Biochimica et biophysica acta,1850(4),750-8.
MLA Ji, Lili,et al."Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation".Biochimica et biophysica acta 1850.4(2015):750-8.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace